Combined CD25-targeted near infrared photoimmunotherapy (NIR-PIT) and intratumor IL-15 enhance the effectiveness of anti-PD-1 immunotherapy
Abstract Immunotherapies aimed at enhancing anti-cancer immunity are now in wide clinical use. For instance, anti-programmed cell death protein 1 (PD-1) monoclonal antibody (mAb) therapy has demonstrated clinical efficacy in many tumor types, but overall, only a minority of patients respond. Near-in...
Збережено в:
| Автори: | , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Springer
2025-12-01
|
| Серія: | Cancer Immunology, Immunotherapy |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1007/s00262-025-04186-x |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
